SCHEMBL21036286

SCHEMBL21036286

CC(C)(C)OC(=O)N[C@H]1CCN(C(=O)[C@@H]2C[C@H](Oc3ccc(-c4ccc(Cl)cc4)cc3)CCN2S(=O)(=O)c2ccc3cc(OC4CCCC4)ccc3c2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 5/20 0.38
ITGB1 P05556 1/20 0.38
ITGA4 P13612 1/20 0.38
GPR119 Q8TDV5 1/20 0.37
HTR1A P08908 2/20 0.36
HTR7 P34969 2/20 0.36
HTR5A P47898 2/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
HTR6 P50406 1/20 0.36
HTR4 Q13639 1/20 0.36
EPHX2 P34913 2/20 0.36
KCNQ1 P51787 1/20 0.36
HRH1 P35367 2/20 0.36
CCR3 P51677 2/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21036257 1.00 GHSR (0.38) GHSRITGB1ITGA4GPR119HTR1A
SCHEMBL21034998 1.00 GHSR (0.38) GHSRITGB1ITGA4GPR119HTR1A
SCHEMBL21035515 1.00 GHSR (0.38) GHSRITGB1ITGA4GPR119HTR1A
SCHEMBL21035531 0.96 ITGB1 (0.38) GHSRITGB1ITGA4GPR119HTR1A
SCHEMBL21035112 0.96 ITGB1 (0.38) GHSRITGB1ITGA4GPR119HTR1A
SCHEMBL21036266 0.94 ITGB1 (0.40) ITGB1ITGA4GPR119HTR1AHTR7
SCHEMBL21035131 0.90 ITGB1 (0.38) ITGB1ITGA4GPR119HTR1AHTR7
SCHEMBL21035008 0.90 ITGB1 (0.38) ITGB1ITGA4GPR119HTR1AHTR7
SCHEMBL21035117 0.90 LMNA (0.39) ITGB1ITGA4GPR119HTR1AHTR7
SCHEMBL21035077 0.90 LMNA (0.39) ITGB1ITGA4GPR119HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed